| increase in admissions for neisseria meningitidis infection in australia. | | 1989 | 2574397 |
| meningococcal disease and the law: does non-notification really happen? | in victoria, legislation clearly makes the notification of clinical or confirmed cases of meningococcal disease mandatory. statistical modelling suggests that meningococcal disease is significantly under-notified, and that incorrect codes might be being ascribed to some in-patient episodes. the aims of this study were (i) to test the assumption that cases identified as non-notified cases were true cases, and (ii) to identify the reasons for non-detection on the hospital separation database and n ... | 1999 | 10736954 |
| annual report of the australian meningococcal surveillance programme, 1999. | the national neisseria network has undertaken meningococcal isolate surveillance by means of a collaborative laboratory based initiative since 1994. the phenotype (serogroup, serotype and serosubtype) and antibiotic susceptibility of 368 isolates of neisseria meningitidis from invasive cases of meningococcal disease were determined in 1999. ninety percent of the invasive isolates were either serogroup b or c. serogroup b strains predominated in all states and territories and were isolated from s ... | 2000 | 10981347 |
| should programmes for community-level meningococcal vaccination be considered in australia? an economic evaluation. | disease due to serogroup c neisseria meningitidis is life-threatening and potentially preventable by vaccination. in 1999, the uk instigated mass vaccination after a sustained increase in serogroup c meningococcal disease. in the same year, victoria, australia experienced a similar change in disease epidemiology. it is timely to undertake an economic evaluation of options for community vaccination in australia based on local data. | 2001 | 11416085 |
| annual report of the australian meningococcal surveillance programme, 2000. | the national neisseria network has undertaken meningococcal isolate surveillance by means of a collaborative laboratory based initiative since 1994. the phenotype (serogroup, serotype and serosubtype) and antibiotic susceptibility of 388 isolates of neisseria meningitidis from invasive cases of meningococcal disease were determined in 2000. more than 90 per cent of the invasive isolates were either serogroup b or c. there was however, considerable diversity in the phenotypes circulating in the d ... | 2001 | 11596711 |
| an outbreak of serogroup c meningococcal disease associated with a secondary school. | an outbreak of 3 cases of invasive meningococcal disease occurred in a secondary school on 2 campuses in victoria. despite having only one isolate (a c.2a:nst strain), meningococcal dna was identified by polymerase chain reaction (pcr) in early culture-negative blood specimens of the other 2 cases. both were subsequently shown by pcr to be capsule serogroup c by pcr. an committee was formed to manage the response to the outbreak. chemoprophylaxis was offered to family and children who had been i ... | 2001 | 11596712 |
| meningococcal vaccination for adolescents? an economic evaluation in victoria. | to undertake an economic evaluation of the options for vaccination of adolescents using meningococcal polysaccharide vaccine based on victorian data. | 2001 | 11885733 |
| increase in meningococcal disease associated with the emergence of a novel st-11 variant of serogroup c neisseria meningitidis in victoria, australia, 1999-2000. | in the years 1999-2000, there was an increase in the incidence of meningococcal disease in victoria, largely caused by neisseria meningitidis serogroup c. this change was associated with a shift in age distribution of cases, with relatively more disease appearing in the 15-29 year age group, and with 40/58 serogroup c isolates in 2000 exhibiting a new macrorestriction pattern (pattern a). thirty-four of 52 pattern a isolates tested displayed the novel phenotype c:2a:p1.4, and were consistently p ... | 2002 | 11895093 |
| annual report of the australian meningococcal surveillance programme, 2001. | since 1994, the national neisseria network has examined and analysed isolates of neisseria meningitidis from cases of invasive meningococcal disease in australia by means of a collaborative laboratory program. the phenotypes (serogroup, serotype and serosubtype) and antibiotic susceptibility of 338 isolates of n. meningitidis from invasive cases of meningococcal disease were determined in 2001. most disease was caused by serogroup b (206 isolates, 61%) or serogroup c (122 isolates, 36%) meningoc ... | 2002 | 12416703 |
| annual report of the australian meningococcal surveillance programme, 2002. | since 1994, the national neisseria network, a nationwide collaborative laboratory program, has examined and analysed isolates of neisseria meningitidis from cases of invasive meningococcal disease in australia. the phenotypes (serogroup, serotype and serosubtype) and antibiotic susceptibility of 393 isolates of n. meningitidis from invasive cases of meningococcal disease were determined in 2002. most disease was caused by serogroup b (210 isolates, 53%) or serogroup c (162 isolates, 41%) meningo ... | 2003 | 12926735 |
| annual report of the australian meningococcal surveillance programme, 2003. | this tenth report by the national neisseria network, a nation-wide collaborative laboratory program, describes 494 laboratory-confirmed cases of meningococcal disease in australia, diagnosed in 2003. the phenotypes (serogroup, serotype and serosubtype) and antibiotic susceptibility of 303 isolates of neisseria meningitidis from invasive cases of meningococcal disease were determined, and an additional 191 cases were confirmed by non-culture-based methods. the age distribution of invasive meningo ... | 2004 | 15460956 |
| annual report of the australian meningococcal surveillance programme, 2005. | in 2005 there were 345 laboratory-confirmed cases of invasive meningococcal disease (imd) analysed by the national neisseria network, a nationwide network of reference laboratories. the phenotypes (serogroup, serotype and serosubtype) and antibiotic susceptibility of 214 isolates of neisseria meningitidis from invasive cases of meningococcal disease were determined and an additional 131 cases were confirmed by non-culture-based methods. nationally, 251 (73%) confirmed cases were infected with se ... | 2006 | 16841503 |
| plastic surgery management of soft tissue loss in meningococcal septicemia: experience of the melbourne royal children's hospital. | soft tissue necrosis associated with meningococcemia is a major challenge for any pediatric plastic surgery service. records of patients treated by the department of plastic and maxillofacial surgery, royal children's hospital, melbourne, australia, were reviewed. two hundred fifty patients were treated for meningococcemia at our institution over a 40-year period. of these, 31 patients suffered soft tissue necrosis. three groups were identified: lesions that healed with nonoperative management ( ... | 2007 | 17471138 |
| annual report of the australian meningococcal surveillance programme, 2007--amended. | in 2007 there were 281 laboratory-confirmed cases of invasive meningococcal disease analysed by the national neisseria network, a nationwide network of reference laboratories. the phenotypes (serogroup, serotype and serosubtype) and antibiotic susceptibility of 154 isolates of neisseria meningitidis from invasive cases of meningococcal disease were determined and an additional 127 cases were confirmed by non-culture based methods. nationally, 223 (85%) confirmed cases where a serogroup was deter ... | 2009 | 19618762 |
| increase in meningococcal serogroup w disease, victoria, australia, 2013-2015. | in victoria, australia, invasive meningococcal disease caused by neisseria meningitidis serogroup w increased from 4% of all cases in 2013 to 30% in 2015. this increase resulted largely from strains similar to those in the serogroup w sequence type 11 clonal complex, previously described in the united kingdom and south america. | 2016 | 27648521 |
| rising incidence of invasive meningococcal disease caused by neisseria meningitidis serogroup w in victoria. | | 2016 | 27078598 |